THU0044 Chondroitin sulphate inhibits monocyte chemoattractant protein-1 release from 3T3L1 adipocytes: a new treatment opportunity for obesity-related metabolic syndromes?
Publication
, Conference
Montell, E; Stabler, TV; Kraus, VB
Published in: Annals of the Rheumatic Diseases
June 2017
Duke Scholars
Published In
Annals of the Rheumatic Diseases
DOI
ISSN
0003-4967
Publication Date
June 2017
Volume
76
Start / End Page
215 / 216
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Montell, E., Stabler, T. V., & Kraus, V. B. (2017). THU0044 Chondroitin sulphate inhibits monocyte chemoattractant protein-1 release from 3T3L1 adipocytes: a new treatment opportunity for obesity-related metabolic syndromes? In Annals of the Rheumatic Diseases (Vol. 76, pp. 215–216). Elsevier BV. https://doi.org/10.1136/annrheumdis-2017-eular.2140
Montell, E., T. V. Stabler, and V. B. Kraus. “THU0044 Chondroitin sulphate inhibits monocyte chemoattractant protein-1 release from 3T3L1 adipocytes: a new treatment opportunity for obesity-related metabolic syndromes?” In Annals of the Rheumatic Diseases, 76:215–16. Elsevier BV, 2017. https://doi.org/10.1136/annrheumdis-2017-eular.2140.
Montell E, Stabler TV, Kraus VB. THU0044 Chondroitin sulphate inhibits monocyte chemoattractant protein-1 release from 3T3L1 adipocytes: a new treatment opportunity for obesity-related metabolic syndromes? In: Annals of the Rheumatic Diseases. Elsevier BV; 2017. p. 215–6.
Montell, E., et al. “THU0044 Chondroitin sulphate inhibits monocyte chemoattractant protein-1 release from 3T3L1 adipocytes: a new treatment opportunity for obesity-related metabolic syndromes?” Annals of the Rheumatic Diseases, vol. 76, Elsevier BV, 2017, pp. 215–16. Crossref, doi:10.1136/annrheumdis-2017-eular.2140.
Montell E, Stabler TV, Kraus VB. THU0044 Chondroitin sulphate inhibits monocyte chemoattractant protein-1 release from 3T3L1 adipocytes: a new treatment opportunity for obesity-related metabolic syndromes? Annals of the Rheumatic Diseases. Elsevier BV; 2017. p. 215–216.
Published In
Annals of the Rheumatic Diseases
DOI
ISSN
0003-4967
Publication Date
June 2017
Volume
76
Start / End Page
215 / 216
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences